---
aliases: [Braidwell LP]
---
#actor #company #hedgefund #healthcare #usa #private

**Braidwell** — Healthcare/life sciences investment firm. $3.8B AUM. Flexible capital across public, private, structured markets. Founded 2021.

---

## Overview

| Metric | Value |
|--------|-------|
| Founded | 2021 |
| HQ | Stamford, CT |
| AUM | $3.8B |
| Focus | Healthcare, life sciences |
| Strategy | Long/short equity + structured capital |

---

## Investment approach

| Aspect | Description |
|--------|-------------|
| Sectors | Biotech, pharma, medical devices, diagnostics |
| Markets | Public, private, structured |
| Stage | All stages of development |
| Capital structure | Flexible (equity, debt, warrants) |

---

## Team expertise

- Investment research
- Medical science
- Biostatistics
- Commercial analysis
- Financial structuring
- Data/computer science
- Portfolio engineering

---

## Notable investments

| Company | Sector | Deal |
|---------|--------|------|
| [[Proxima]] | [[AI drug discovery]] | $80M seed participant |
| Caris [[Life Sciences]] | Diagnostics | Led $168M round (Apr 2025) |
| Nevro Corp | Medical devices | $200M term loan + warrants |
| Impulse Dynamics | Therapeutic devices | Dec 2025 |
| NovoCure | Oncology devices | Public holding |
| Xenon Pharma | Neurology | Public holding |
| CG Oncology | Oncology | Public holding |

---

## Top holdings (public)

| Company | Focus |
|---------|-------|
| Caris [[Life Sciences]] | Precision medicine |
| NovoCure | Tumor treating fields |
| Xenon Pharmaceuticals | Neurology |
| CG Oncology | Bladder cancer |
| Neurocrine Biosciences | CNS disorders |

---

*Created 2026-01-17*

---

## Related

- [[Proxima]] — portfolio company
- [[Biotech]] — sector focus
- [[Healthcare]] — sector focus
